
Overview
Background
Dr Jodi Saunus is a senior fellow who specialises in translational research on metastatic breast cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research in 2022 to help facilitate patient-focused research at the interface of biomedical R&D and clinical practice.
Dr Saunus has an honours degree in biochemistry and biomedical science, a PhD in breast cancer molecular genetics, and broad post-doctoral experience in immunology, molecular cell biology, pathology informatics, and early-phase investigator-initiated clinical trials. Her current portfolio focuses finding new ways to improve the clinical management of aggressive breast cancer, with a focus on triple-negative breast cancer, and the prevention and treatment of brain metastases. This work spans across multiple disciplines and capabilities, and broadly involves:
- Molecular profiling of patient-donated blood and tumour tissue samples to identify features that can predict treatment response, or represent previously uncharacterised therapeutic targets.
- Using experimental models of breast cancer metastasis to learn about the molecular mechanisms exploited by cancer cells to survive and grow in brain tissue.
- Developing innovative treatment strategies that work differently to conventional cancer drugs, including alpha-particle endoradiotherapy and in-situ vaccination.
With an outstanding network of collaborators from academia and clinical practice, she has secured more than $6M to fund this work and has a track record of publishing in prominent biomedical research journals (e.g., Cancer Research, Nature, Science Translational Medicine, Nature Communications and The Journal of Pathology).
Peripherally, Jodi is a strong proponent of biospecimen banking, and clinician and consumer engagement in translational research.
Availability
- Dr Jodi Saunus is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, The University of Queensland
Research interests
-
Biomarkers of triple-negative breast cancer progression and response to therapy
Using published datasets, and tissue donated by Brisbane breast cancer patients, we're trying to identify new biomarkers of prognosis and treatment response in breast cancer.
-
Understanding how the triple-negative breast cancer transcriptome is rewired during tumour progression
We apply mathematical approaches to analyse transcriptional networks in TNBC, illuminating how cell biology evolves during tumour development and post-treatment relapse.
-
Understanding the brain metastasis immune microenvironment
In collaboration with immuno-oncology experts at the Peter MacCallum Cancer Centre in Melbourne, we are studying the expression of common tumour antigens to develop strategies for vaccination against cancer.
-
Therapeutic antibody uptake in brain metastases
Brain metastases are broadly refractory to existing systemic therapies. We believe that abnormal vascular function and interstitial fluid dynamics in these tumours may contribute more than previously appreciated. We aim to engineer molecular-targeted carriers that improve the effectiveness and reduce the side-effects of radiotherapy and chemotherapy.
Works
Search Professor Jodi Saunus’s works on UQ eSpace
2021
Journal Article
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
Johnson, Nichola, Maguire, Sarah, Morra, Anna, Kapoor, Pooja Middha, Tomczyk, Katarzyna, Jones, Michael E., Schoemaker, Minouk J., Gilham, Clare, Bolla, Manjeet K., Wang, Qin, Dennis, Joe, Ahearn, Thomas U., Andrulis, Irene L., Anton-Culver, Hoda, Antonenkova, Natalia N., Arndt, Volker, Aronson, Kristan J., Augustinsson, Annelie, Baynes, Caroline, Freeman, Laura E. Beane, Beckmann, Matthias W., Benitez, Javier, Bermisheva, Marina, Blomqvist, Carl, Boeckx, Bram, Bogdanova, Natalia V., Bojesen, Stig E., Brauch, Hiltrud, Brenner, Hermann ... Fletcher, Olivia (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4), 842-854. doi: 10.1038/s41416-020-01185-w
2020
Journal Article
Breast cancer polygenic risk score and contralateral breast cancer risk
Kramer, Iris, Hooning, Maartje J., Mavaddat, Nasim, Hauptmann, Michael, Keeman, Renske, Steyerberg, Ewout W., Giardiello, Daniele, Antoniou, Antonis C., Pharoah, Paul D.P., Canisius, Sander, Abu-Ful, Zumuruda, Andrulis, Irene L., Anton-Culver, Hoda, Aronson, Kristan J., Augustinsson, Annelie, Becher, Heiko, Beckmann, Matthias W., Behrens, Sabine, Benitez, Javier, Bermisheva, Marina, Bogdanova, Natalia V., Bojesen, Stig E., Bolla, Manjeet K., Bonanni, Bernardo, Brauch, Hiltrud, Bremer, Michael, Brucker, Sara Y., Burwinkel, Barbara, Castelao, Jose E. ... Schmidt, Marjanka K. (2020). Breast cancer polygenic risk score and contralateral breast cancer risk. American Journal of Human Genetics, 107 (5), 837-848. doi: 10.1016/j.ajhg.2020.09.001
2020
Journal Article
Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1
Kalaw, Emarene, Lim, Malcolm, Kutasovic, Jamie R., Sokolova, Anna, Taege, Lucinda, Johnstone, Kate, Bennett, James, Saunus, Jodi M., Niland, Colleen, Ferguson, Kaltin, Gresshoff, Irma, Bettington, Mark, Pathmanathan, Nirmala, Tse, Gary M., Papadimos, David, Pathmanathan, Rajadurai, Harris, Gavin, Yamaguchi, Rin, Tan, Puay Hoon, Fox, Stephen, O’Toole, Sandra A., Simpson, Peter T., Lakhani, Sunil R. and McCart Reed, Amy E. (2020). Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1. British Journal of Cancer, 123 (11), 1665-1672. doi: 10.1038/s41416-020-01065-3
2020
Journal Article
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases
Kalita-de Croft, Priyakshi, Lim, Malcolm, Chittoory, Haarika, de Luca, Xavier M., Kutasovic, Jamie R., Day, Bryan W., Al-Ejeh, Fares, Simpson, Peter T., McCart Reed, Amy E., Lakhani, Sunil R. and Saunus, Jodi M. (2020). Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases. Therapeutic Advances in Medical Oncology, 12 1758835920946259, 175883592094625. doi: 10.1177/1758835920946259
2020
Journal Article
Association of sperm-associated antigen 5 and treatment response in patients with estrogen receptor-positive breast cancer
Abdel-Fatah, Tarek M. A., Ball, Graham R., Thangavelu, Pulari U., Reid, Lynne E., McCart Reed, Amy E., Saunus, Jodi M., Duijf, Pascal H. G., Simpson, Peter T., Lakhani, Sunil R., Pongor, Lorinc, Gyorffy, Balázs, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Caldas, Carlos, Ellis, Ian O. and Chan, Stephen Y. T. (2020). Association of sperm-associated antigen 5 and treatment response in patients with estrogen receptor-positive breast cancer. JAMA Network Open, 3 (7) e209486, e209486. doi: 10.1001/jamanetworkopen.2020.9486
2020
Journal Article
Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases
Zhang, Lin, Yao, Jun, Wei, Yongkun, Zhou, Zhifen, Li, Ping, Qu, Jingkun, Badu-Nkansah, Akosua, Yuan, Xiangliang, Huang, Yu-Wen, Fukumura, Kazutaka, Mao, Xizeng, Chang, Wei-Chao, Saunus, Jodi, Lakhani, Sunil, Huse, Jason T., Hung, Mien-Chie and Yu, Dihua (2020). Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases. Science Translational Medicine, 12 (545) eaaz5387, eaaz5387. doi: 10.1126/scitranslmed.aaz5387
2020
Journal Article
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
Adwal, Alaknanda, Kalita-de Croft, Priyakshi, Shakya, Reshma, Lim, Malcolm, Kalaw, Emarene, Taege, Lucinda D., McCart Reed, Amy E., Lakhani, Sunil R., Callen, David F. and Saunus, Jodi M. (2020). Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer. Life Science Alliance, 3 (7) e201900562, 1-12. doi: 10.26508/lsa.201900562
2020
Other Outputs
Hotspot KRAS mutations in brain metastases at the first metastatic recurrence of cutaneous melanoma
Rabbie, Roy, Ferguson, Peter, Wong, Kim, Moran, Una, Turner, Clinton, Emanuel, Patrick, Haas, Kerstin, Saunus, Jodi M., Davidson, Morgan R., Lakhani, Sunil R., Shivalingam, Brindha, Long, Georgina V., Parkinson, Christine, Osman, Iman, Scolyer, Richard A., Corrie, Pippa and Adams, David J. (2020). Hotspot KRAS mutations in brain metastases at the first metastatic recurrence of cutaneous melanoma. doi: 10.1101/2020.02.17.952630
2020
Journal Article
Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking
Gedye, Craig, Sachchithananthan, Mythily, Leonard, Robyn, Jeffree, Rosalind L., Buckland, Michael E., Ziegler, David S., Graeber, Manuel B., Day, Bryan W., McDonald, Kerrie L., Lasocki, Arian, Back, Michael, Besser, Michael, Boyd, Andrew, Buckland, Michael, Byrne, Jennifer, Cher, Lawrence, Cook, Raymond, Day, Bryan, Day, Jerry, Davidson, Andrew, Devereux, Lisa, Dexter, Mark, Donnelly, Roy, Drummond, Kate, Eckstein, Lisa, Gan, Hui, Garrick, Therese, Gedye, Craig, Gottardo, Nick ... Nowak, Anna K (2020). Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking. Neuro-Oncology Practice, 7 (1), 31-37. doi: 10.1093/nop/npz036
2020
Journal Article
Non-coding RNAs underlie genetic predisposition to breast cancer
Moradi Marjaneh, Mahdi, Beesley, Jonathan, O'Mara, Tracy A., Mukhopadhyay, Pamela, Koufariotis, Lambros T., Kazakoff, Stephen, Hussein, Nehal, Fachal, Laura, Bartonicek, Nenad, Hillman, Kristine M., Kaufmann, Susanne, Sivakumaran, Haran, Smart, Chanel E., McCart Reed, Amy E., Ferguson, Kaltin, Saunus, Jodi M., Lakhani, Sunil R., Barnes, Daniel R., Antoniou, Antonis C., Dinger, Marcel E., Waddell, Nicola, Easton, Douglas F., Dunning, Alison M., Chenevix-Trench, Georgia, Edwards, Stacey L. and French, Juliet D. (2020). Non-coding RNAs underlie genetic predisposition to breast cancer. Genome Biology, 21 (1) 7, 7. doi: 10.1186/s13059-019-1876-z
2020
Conference Publication
Remodelling of calcium influx pathways in breast cancer associated fibroblasts
Sadras, Francisco, Stewart, Teneale A., Robitaille, Melanie, Peters, Amelia A., Kalita-de Croft, Priyakshi, Soon, Patsy, Saunus, Jodi M., Lakhani, Sunil R., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2020). Remodelling of calcium influx pathways in breast cancer associated fibroblasts. 2019 San Antonio Breast Cancer Symposium, San Antonio, TX United States, 10-14 December 2019. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.sabcs19-p6-06-15
2020
Journal Article
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Fachal, Laura, Aschard, Hugues, Beesley, Jonathan, Barnes, Daniel R., Allen, Jamie, Kar, Siddhartha, Pooley, Karen A., Dennis, Joe, Michailidou, Kyriaki, Turman, Constance, Soucy, Penny, Lemaçon, Audrey, Lush, Michael, Tyrer, Jonathan P., Ghoussaini, Maya, Marjaneh, Mahdi Moradi, Jiang, Xia, Agata, Simona, Aittomäki, Kristiina, Alonso, M. Rosario, Andrulis, Irene L., Anton-Culver, Hoda, Antonenkova, Natalia N., Arason, Adalgeir, Arndt, Volker, Aronson, Kristan J., Arun, Banu K., Auber, Bernd, Auer, Paul L. ... Dunning, Alison M. (2020). Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics, 52 (1), 56-73. doi: 10.1038/s41588-019-0537-1
2020
Conference Publication
Calcium communication in an in vitro model of breast cancer brain metastases
Chalmers, Silke B., Sadras, Francisco, Saunus, Jodi , Lakhani, Sunil , Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2020). Calcium communication in an in vitro model of breast cancer brain metastases. ASCEPT-APSA Joint virtual scientific meeting 2020, Virtual meeting, 24-26 November 2020.
2019
Journal Article
Calcium signalling and breast cancer
So, Choon Leng, Saunus, Jodi M., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2019). Calcium signalling and breast cancer. Seminars in Cell & Developmental Biology, 94, 74-83. doi: 10.1016/j.semcdb.2018.11.001
2019
Journal Article
LobSig is a multigene predictor of outcome in invasive lobular carcinoma
McCart Reed, Amy E., Lal, Samir, Kutasovic, Jamie R., Wockner, Leesa, Robertson, Alan, de Luca, Xavier M., Kalita-de Croft, Priyakshi, Dalley, Andrew J., Coorey, Craig P., Kuo, Luyu, Ferguson, Kaltin, Niland, Colleen, Miller, Gregory, Johnson, Julie, Reid, Lynne E., Males, Renique, Saunus, Jodi M., Chenevix-Trench, Georgia, Coin, Lachlan, Lakhani, Sunil R. and Simpson, Peter T. (2019). LobSig is a multigene predictor of outcome in invasive lobular carcinoma. npj Breast Cancer, 5 (1) 18, 18. doi: 10.1038/s41523-019-0113-y
2019
Journal Article
Proteomic analysis of the breast cancer brain metastasis microenvironment
Kalita-de Croft, Priyakshi, Straube, Jasmin, Lim, Malcolm, Al-Ejeh, Fares, Lakhani, Sunil R. and Saunus, Jodi M. (2019). Proteomic analysis of the breast cancer brain metastasis microenvironment. International Journal of Molecular Sciences, 20 (10) 2524, 2524. doi: 10.3390/ijms20102524
2019
Journal Article
Innovative therapeutic strategies for effective treatment of brain metastases
Lim, Malcolm, Puttick, Simon, Houston, Zachary H., Thurecht, Kristofer J., Kalita-de Croft, Priyakshi, Mahler, Stephen, Rose, Stephen E., Jeffree, Rosalind L., Mazzieri, Roberta, Dolcetti, Riccardo, Lakhani, Sunil R. and Saunus, Jodi M. (2019). Innovative therapeutic strategies for effective treatment of brain metastases. International Journal of Molecular Sciences, 20 (6) 1280, 1280. doi: 10.3390/ijms20061280
2019
Journal Article
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer
Wiegmans, Adrian P., Saunus, Jodi M., Ham, Sunyoung, Lobb, Richard J., Kutasovic, Jamie R., Dalley, Andrew J., Miranda, Mariska, Atkinson, Caroline, Foliaki, Simote T., Ferguson, Kaltin, Niland, Colleen, Johnstone, Cameron N., Lewis, Victoria, Collins, Steven, Lakhani, Sunil R., Al-Ejeh, Fares and Möller, Andreas (2019). Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer. JCI Insight, 5 (6) e124092. doi: 10.1172/jci.insight.124092
2019
Journal Article
Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications
McCart Reed, Amy Ellen, Kalaw, Emarene, Nones, Katia, Bettington, Mark, Lim, Malcolm, Bennett, James, Johnstone, Kate, Kutasovic, Jamie Rose, Saunus, Jodi Marie, Kazakoff, Stephen, Xu, Qinying, Wood, Scott, Holmes, Oliver, Leonard, Conrad, Reid, Lynne Estelle, Black, Debra, Niland, Colleen, Ferguson, Kaltin, Gresshoff, Irma, Raghavendra, Ashwini, Harvey, Kate, Cooper, Caroline, Liu, Cheng, Kalinowski, Lauren, Reid, Andrew Scott, Davidson, Morgan, Pearson, John V, Pathmanathan, Nirmala, Tse, Gary ... Lakhani, Sunil R. (2019). Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications. Journal of Pathology, 247 (2), 214-227. doi: 10.1002/path.5184
2019
Conference Publication
Dissecting the heterogeneity of metaplastic breast cancer: a morphological, immunohistochemical and genomic analysis of a large cohort
Reed, A. E. McCart, Kalaw, E., Nones, K., Bettington, M., Lim, M., Bennett, J., Johnstone, K., Kutasovic, J. R., Kazakoff, S., Xu, Q. C., Saunus, J. M., Reid, L. E., Black, D., Niland, C., Ferguson, K., Gresshoff, I., Raghavendra, A., Liu, J. C., Kalinowski, L., Reid, A. S., Davidson, M., Pearson, J. V., Yamaguchi, R., Harris, G., Tse, G., Papadimos, D., Pathmanathan, R., Pathmanathan, N., Tan, P. H. ... Lakhani, S. R. (2019). Dissecting the heterogeneity of metaplastic breast cancer: a morphological, immunohistochemical and genomic analysis of a large cohort. San Antonio Breast Cancer Symposium, San Antonio, TX, United States, 4-8 December 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-P3-08-03
Funding
Current funding
Supervision
Availability
- Dr Jodi Saunus is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Development of new theranostic agents for metastatic breast cancer surveillance and treatment
Most of the time, treatments for early breast cancer successfully prevent metastatic spread, but 10% of Australian patients still develop lethal recurrences within 5 years. Rather than waiting to see which patients develop symptoms of a possible relapse (e.g., headaches, respiratory symptoms), we are getting better at detecting metastasis early. Patients deemed to be at ‘high risk’ are offered regular PET or MRI scans, allowing earlier intervention and better quality-of-life. PET imaging of radioactive tracers is more specific than MRI, but the standard tracer used in oncology – [18F]fluorodeoxyglucose (FDG) – is not useful for imaging the brain. We are seeking a student to help us develop agents that seek out tumour cells more specifically than FDG and can also be engineered to function as therapeutics. The project is flexible depending on the successful candidate’s expertise and interest (e.g., in vivo models of metastatic breast cancer, protein chemistry and/or molecular biology).
Supervision history
Current supervision
-
Doctor Philosophy
Epigenomic determinants of chemotherapy response in triple-negative breast cancer
Principal Advisor
Other advisors: Professor Chris Pyke, Associate Professor Adam Ewing
-
Doctor Philosophy
Investigating the diagnostic and functional significance of specific epigenomic features in triple-negative breast cancer (TNBC)
Principal Advisor
Other advisors: Honorary Professor Kum Kum Khanna
-
Doctor Philosophy
Epigenomic determinants of chemotherapy response in triple-negative breast cancer
Principal Advisor
Other advisors: Professor Chris Pyke, Associate Professor Adam Ewing
-
Master Philosophy
Treatment patterns and prognostic indicators in triple-negative breast cancer: a multicentre study of contemporary cases from Queensland, Australia
Principal Advisor
Other advisors: Professor Chris Pyke
-
Master Philosophy
Development and characterization of bispecific and bivalent nanobodies for targeting ErBb receptors
Associate Advisor
Other advisors: Dr Nick Fletcher, Dr Pie Huda, Professor Kristofer Thurecht
-
Doctor Philosophy
Factors impacting receptor processing in response to peptide and antibody ligands
Associate Advisor
-
Doctor Philosophy
Obesity and triple-negative breast cancer: an epidemiological study
Associate Advisor
Other advisors: Dr Melinda Protani, Dr Louise Marquart-Wilson
-
Doctor Philosophy
Triple-negative breast cancer in Australia: investigating factors associated with prognosis
Associate Advisor
Other advisors: Dr Melinda Protani, Dr Louise Marquart-Wilson
-
Doctor Philosophy
Applying long-read sequencing technologies to cancer genomes
Associate Advisor
Other advisors: Dr Yuanhao Yang, Dr Sandra Richardson, Associate Professor Adam Ewing
-
Doctor Philosophy
Strategies to improve immunotherapy for patients with glioblastoma or breast cancer brain metastases
Associate Advisor
Other advisors: Professor Fiona Simpson, Professor Nikolas Haass
-
Doctor Philosophy
The effect of avidity on nanobody-based formats for theranostic applications
Associate Advisor
Other advisors: Dr Nick Fletcher, Dr Pie Huda, Professor Kristofer Thurecht
Completed supervision
-
2022
Doctor Philosophy
Development of theranostic nanomedicines for breast cancer brain metastases
Principal Advisor
Other advisors: Professor Sunil Lakhani
-
2022
Doctor Philosophy
Investigation of epigenetic influences on DNA methylation in Triple Negative Breast Cancer
Principal Advisor
Other advisors: Professor Melissa Brown, Professor Sunil Lakhani
-
2021
Doctor Philosophy
Detailed Characterisation of Metaplastic Breast Carcinoma
Associate Advisor
Other advisors: Professor Sunil Lakhani, Associate Professor Amy McCart Reed
-
2016
Doctor Philosophy
Identification of new prognostic biomarker for triple negative breast cancer
Associate Advisor
Other advisors: Professor Sunil Lakhani, Associate Professor Peter Simpson
-
2015
Doctor Philosophy
Heregulin/HER3 signalling increases invasive behaviour of HER2-positive breast cancer cells
Associate Advisor
Other advisors: Professor Sunil Lakhani
Media
Enquiries
Contact Dr Jodi Saunus directly for media enquiries about:
- brain metastases
- breast cancer
- metastatic breast cancer
- stage IV breast cancer
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: